Doug Ingram’s force of will meets its match as Sarepta CEO plans to depart news2026-02-26T20:17:18+00:00February 26th, 2026|Endpoints News|
FDA probes internal Prasad complaints with outside helpnews2026-02-26T20:13:02+00:00February 26th, 2026|Endpoints News|
Boehringer wins accelerated approval for first-line use of lung cancer drugnews2026-02-26T20:03:47+00:00February 26th, 2026|Endpoints News|
Viatris plans to lay off up to 10% of staff, discloses Indian factory fire news2026-02-26T18:09:12+00:00February 26th, 2026|Endpoints News|
Make way, Camzyos: Cytokinetics touts promising early launch for rival heart drugnews2026-02-25T20:17:20+00:00February 25th, 2026|Endpoints News|
Charles River sells its CDMO and European discovery businessesnews2026-02-25T16:22:03+00:00February 25th, 2026|Endpoints News|
States sue Kennedy over US childhood vaccine overhaulnews2026-02-25T14:57:13+00:00February 25th, 2026|Endpoints News|
Novo Nordisk teams with Langer-founded biotech for oral obesity drugsnews2026-02-25T13:00:59+00:00February 25th, 2026|Endpoints News|
Novo Nordisk to slash Wegovy list price in half in 2027 news2026-02-24T20:38:01+00:00February 24th, 2026|Endpoints News|
